Acute Migraine Clinical Trial
Official title:
Evaluation of Brain Activation in Complete Responders and Partial Responders Following Acute Administration of Treximet (Sumatriptan and Naproxen)
We are looking for volunteers who suffer from acute migraine (<14 episodes per month) to participate in a 2-visit brain imaging research study. The goal of the study is to observe the effect of acute administration of Treximet during a migraine episode on the pain pathways of the migraine brain. Visit 1 will consist of 1 hour, where participants will be signing the informed consent form, completing questionnaires, meeting with the study physician, and having QST (sensory testing to determine individual pain thresholds to a heat stimulus) performed. Visit 2 will occur during a migraine episode. Volunteers will be asked to contact the study team at the first onset of a migraine. Upon arrival at Visit 2, individuals will be given an IV for blood draws. Once these the IV is in place, subjects will enter the MRI and be asked to stay very still. Scanning will occur for about 20 minutes, and then subjects will be given a Treximet tablet to combat their migraine. More scanning will follow Treximet administration. Some scans will have no stimulation, and others will apply a heat stimulus that subjects will rate using a pain scale. Seven 5-mL blood samples will be drawn throughout the duration of the MRI session. Both Visit 1 and Visit 2 will be compensated.
n/a
Observational Model: Cohort
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04153409 -
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
|
Phase 2 | |
| Completed |
NCT02279082 -
DFN-02 Open Label Safety Study in Patients With Acute Migraine
|
Phase 3 | |
| Completed |
NCT04574362 -
Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine
|
Phase 3 | |
| Completed |
NCT01973205 -
Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
|
Phase 3 | |
| Terminated |
NCT04089761 -
Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents
|
N/A | |
| Completed |
NCT03631550 -
The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
|
N/A | |
| Completed |
NCT01267864 -
Valproate Versus Ketorolac Versus Metoclopramide
|
Phase 4 | |
| Completed |
NCT05371652 -
A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants
|
Phase 3 | |
| Completed |
NCT04218162 -
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean
|
Phase 3 | |
| Completed |
NCT01730326 -
Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack
|
Phase 4 | |
| Completed |
NCT04408794 -
Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
|
Phase 2/Phase 3 | |
| Completed |
NCT02745392 -
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
|
Phase 2/Phase 3 | |
| Completed |
NCT00894556 -
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
|
Phase 3 | |
| Terminated |
NCT02185703 -
Chordate System S020 Acute Migraine Clinical Investigation
|
N/A | |
| Terminated |
NCT01680029 -
PBASE-system Acute Migraine Clinical Investigation
|
N/A | |
| Completed |
NCT01358279 -
Transcranial Direct Current Stimulation for Migraine Attack
|
N/A | |
| Not yet recruiting |
NCT01228552 -
The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine
|
Phase 3 | |
| Completed |
NCT02684409 -
Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine
|
Phase 1 | |
| Completed |
NCT02439320 -
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
|
Phase 3 | |
| Completed |
NCT01276977 -
Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
|
N/A |